Patient Monitoring Market Set to Reach $10.65B by 2034

The global patient monitoring and ultrasound devices display market is on an upward trajectory, set to hit USD 10.65 billion by 2034 from USD 6.33 billion in 2025, with a projected CAGR of 5.95%. This growth is fueled by the increasing demand for real-time diagnostics and advanced imaging technologies. The market dynamics are revenue-based, with 2024 as the base year.

Artificial intelligence (AI) is revolutionizing patient monitoring and ultrasound devices by enhancing accuracy, safety, and efficiency in medical devices. AI enables rapid and accurate analysis of medical images, leading to high-speed disease detection and prevention. Remote patient monitoring and personalized care trends are driving robust growth opportunities for AI integration in medical devices.

In April 2025, Royal Philips introduced its AI-enabled Elevate Platform upgrade on the EPIQ Elite ultrasound imaging platform in India, showcasing the industry’s commitment to technological advancements.

The market is witnessing transformative growth due to the rising demand for remote patient monitoring, increased healthcare expenditure, and technological advancements. The demand for higher resolution and energy-efficient displays like OLED, micro-LED, and AMOLED is propelling market growth. Governments worldwide are promoting digital health integration, further supporting market expansion.

The prevalence of chronic diseases like cardiovascular diseases, cancer, and diabetes is a key factor driving demand for patient monitoring and ultrasound devices. Early disease detection, remote patient monitoring, and prenatal screening awareness are also contributing to market growth. The market is witnessing advancements in minimally invasive techniques, boosting the adoption of cutting-edge devices.

North America leads the market, driven by the high prevalence of chronic diseases and early adoption of advanced technologies. Asia Pacific is the fastest-growing region, supported by a growing aging population and government initiatives promoting digital health technologies. Europe is experiencing significant growth, emphasizing value-based care models and patient-centric care.

Major market players include Becton, Dickinson and Company, Abbott Laboratories, GE Healthcare Technologies Inc., and others. Recent developments include innovative products like cellular-connected blood pressure monitors and ultrasound blood pressure monitoring systems. The market is segmented by device type, display type, size, display technology, end-user, and region, offering a comprehensive view of the industry landscape.

With a focus on accuracy, relevance, and clarity, the patient monitoring and ultrasound devices display market is poised for continued growth, driven by technological advancements, increasing healthcare needs, and a commitment to improving patient outcomes.